Potential impact of genetic variants in Nrf2 regulated antioxidant genes and risk prediction of diabetes and associated cardiac complications

Current Medicinal Chemistry

Volumn 20, Issue 37, 2013, Pages 4680-4693

  Ramprasath, T ^a   Selvam, G S ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

Author keywords

Cardiovascular disorders; Diabetes; GPx 1; GST; NQO1; Nrf2 ARE

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUCURONOSYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FREE RADICALS; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; OXIDOREDUCTASES;

EID: 84889262397     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990154     Document Type: Article

References (109)

1. Grant, S.F.; Hakonarson. H.; Schwartz, S. Can the Genetics of Type 1 and Type 2 Diabetes Shed Light on the Genetics of Latent Autoimmune Diabetes in Adults? Endocr. Rev., 2010, 31(2), 183-193.
2. National Institute of Diabetes and Digestive and Kidney Diseases 2008 National Diabetes Statistics, 2007 fact sheet. Bethesda, M.D. U.S. Department of Health and Human Services, National Institutes of Health.
3. Kahn, S.E.; Hull, R.L.; Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 2006, 444(7121), 840-846. (Pubitemid 46024990)
4. Danaei, G.; Finucane, M.M.; Lu, Y.; Singh, G.M.; Cowan, M.J.; Paciorek, C.J.; Lin, J.K.; Farzadfar, F.; Khang, Y.H.; Stevens, G.A.; Rao, M.; Ali, M.K.; Riley, L.M.; Robinson, C.A.; Ezzati, M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 countryyears and 2.7 million participants. Lancet, 2011, 378(9785), 31-40.
5. Blendea, M.C.; McFarlane, S.I.; Isenovic, E.R.; Gick, G.; Sowers, J.R. Heart disease in diabetic patients. Curr. Diab. Rep., 2003, 3(3), 223-229. (Pubitemid 38906776)
6. Vanninen, E.; Mustonen, J.; Vainio, P.; Lansimies, E.; Uusitupa, M. Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am. J. Cardiol., 1992, 70(3), 371-378.
7. Diamant, M.; Lamb, H.J.; Groeneveld, Y.; Endert, E.L.; Smit, J.W.; Bax, J.J.; Romijn, J.A.; de Roos, A.; Radder, J.K. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J. Am. Coll. Cardiol., 2003, 42(2), 328-335. (Pubitemid 36851426)
8. Yamagishi, S.I.; K. Nakamura, T.; Matsui, S.I.; Ueda, T.; Imaizumi. Role of postprandial hyperglycaemia in cardiovascular disease in diabetes. Int. J. Clin. Pract., 2007, 61(1), 83-87.
9. Dominguez-Rodriguez, A.; Abreu-Gonzalez, P.; Garcia-Gonzalez, M.J.; Kaski, J.C. High serum matrix metalloproteinase-9 level predict increased risk of inhospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction. Atherosclerosis, 2008, 196(1), 365-371.
10. Sniderman, A.D.; Bhopal, R.; Prabhakaran, D.; Sarrafzadegan, N.; Tchernof, A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int. Jour. Epidemiol., 2007, 36(1), 220-225. (Pubitemid 47061601)
11. Kohen, R.; Nyska, A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol., 2002, 30(6), 620-650. (Pubitemid 36018731)
12. Wenk, J.; Brenneisen, P.; Wlaschek, M.; Poswig, A.; Briviba, K.; Oberley, T.D.; Scharffetter-Kochanek, K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as major oxidant in the AP-1-mediated induction of matrix-degrading metalloproteinase- 1. J. Biol. Chem., 1999, 274(36), 25869-25876.
13. Robertson, R.P. Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes. J. Biol. Chem., 2004, 279(41), 42351-42354.
14. Wolff, S.P.; Dean, R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J., 1987, 245(1), 243-250. (Pubitemid 17089839)
15. Jiang, Z.Y.; Woollard, A.C.; Wolff, S.P. Hydrogen peroxide production during experimental protein glycation. FEBS Lett., 1990, 268(1), 69-71. (Pubitemid 20233832)
16. Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol., 2003, 552(Pt 2), 335-344. (Pubitemid 37321833)
17. Lin, M.T.; Beal, M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006, 443(7113), 787-795. (Pubitemid 44622683)
18. Ceriello, A. New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy. Diabetes Care, 2003, 26(5), 1589-1596. (Pubitemid 36929196)
19. Itoh, K.; Igarashi, K.; Hayashi, N.; Nishizawa, M.; Yamamoto, M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol. Cell Biol., 1995, 15(8), 4184-4193.
20. Cho, H.Y.; Reddy, S. P.; DeBiase, A.; Yamamoto, M.; Kleeberger, S. R. Gene expression profiling of NRF2 mediated protection against oxidative injury. Free. Radic. Biol. Med., 2005, 38(3), 325-343. (Pubitemid 40081112)
21. Lee, J.M.; Johnson, J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J. Biochem. Mol. Biol., 2004, 37(2), 139-143. (Pubitemid 38608865)
22. Chan, J.Y.; Kwong, M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim. Biophys. Acta, 2000, 1517(1), 19-26.
23. Yamamoto, T.; Suzuki, T.; Kobayashi, A.; Wakabayashi, J.; Maher, J.; Motohashi, H.; Yamamoto, M. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell Biol., 2008, 28(8), 2758-2770. (Pubitemid 351542373)
24. Jain, A.K.; Bloom, D.A.; Jaiswal, A.K. Nuclear import and export signals in control of Nrf2. J. Biol. Chem., 2005, 280(32), 29158-29168. (Pubitemid 41161367)
25. Dhakshinamoorthy, S.; Jaiswal, A.K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene, 2001, 20(29), 3906-3917. (Pubitemid 32646201)
26. Venugopal, R.; Jaiswal, A. K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinine oxidoreductase1 gene. Proc. Natl. Acad. Sci. U.S.A., 1996, 93(25), 14960-14965. (Pubitemid 26419078)
27. Keum, Y. S.; Owuor, E. D.; Kim, B. R.; Hu, R.; Kong, A. N. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm. Res., 2003, 20(9), 1351-1356. (Pubitemid 37164041)
28. Braun, S.; Hanselmann, C.; Gassmann, M.G.; auf dem Keller, U.; Born-Berclaz, C.; Chan, K.; Kan, Y.W.; Werner, S. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound, Mol. Cell. Biol., 2002, 22(15), 5492-5505. (Pubitemid 34755759)
29. Cho, H.Y.; Jedlicka, A.E.; Reddy, S.P.; Kensler, T.W.; Yamamoto, M.; Zhang, L.Y.; Kleeberger, S.R. Role of NRF2 in protection against hyperoxic lung injury in mice, Am. J. Respir. Cell Mol. Biol., 2002, 26(2), 175-182. (Pubitemid 34107870)
30. Chen, X.; Dodd, G.; Thomas, S.; Zhang, X.; Wasserman, M.A.; Rovin, B.H.; Kunsch, C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circ. Physiol., 2006, 290(5), H1862-H1870.
31. Ramprasath, T.; Kumar, P.H.; Puhari, S.S.; Murugan, P.S.; Vasudevan, V.; Selvam, G.S. L-Arginine ameliorates cardiac left ventricular oxidative stress by upregulating eNOS and Nrf2 target genes in alloxan-induced hyperglycemic rats. Biochem. Biophys. Res. Commun., 2012, 428(3), 389-394.
32. Dhakshinamoorthy, S.; Porter, A.G. Nitric oxide-induced transcriptional upregulation of protective genes by Nrf2 via the antioxidant responsive element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem., 2004, 279(19), 20096-20107. (Pubitemid 38623454)
33. Liu, X.M.; Peyton, K.J.; Ensenat, D.; Wang, H.; Hannink, M.; Alam, J.; Durante, W. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc. Res., 2007, 75(2), 381-389. (Pubitemid 46961918)
34. Lee, J.; Surh, Y. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett., 2005, 224(2), 171-184. (Pubitemid 40725839)
35. Kwak, M.; Kensler, T.W. Targeting NRF2 signaling for cancer chemoprevention. Toxicol. Appl. Pharmacol., 2010, 244(1), 66-76.
36. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414 (6865), 813-820. (Pubitemid 34000785)
37. Nishikawa, T.; Edelstein, D.; Du, X.L.; Yamagishi, S.; Matsumura, T.; Kaneda, Y.; Yorek, M.A.; Beebe, D.; Oates, P.J; Hammes, H.P.; Giardino, I.; Brownlee, M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 2000, 404(6779), 787-790. (Pubitemid 30212409)
38. Wautier, M.P.; Chappey, O.; Corda, S.; Stern, D.M.; Schmidt, A.M.; Wautier, J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab., 2001, 280(5), E685-E694.
39. Creager, M.A.; Luscher, T.F.; Cosentino, F.; Beckman, J.A. Diabetes and vascular disease: pathophysiology, clinical consequences and medical therapy: part I, Circulation, 2003, 108(12), 1527-1532. (Pubitemid 37176462)
40. Martin, N.J.; Collier, A.C.; Bowen, L.D.; Pritsos, K.L.; Goodrich, G.G.; Arger, K.; Cutter, G.; Pritsos, C.A. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutat. Res., 2009, 674(1-2), 93-100.
41. Galle, J.; Quaschning, T.; Seibold, S.; Wanner, C. Endothelial dysfunction and inflammation: what is the link? Kidney Int. Suppl., 2003, 84, S45-S49. (Pubitemid 36513373)
42. Izawa, Y.; Yoshizumi, M.; Fujita, Y.; Ali, N.; Kanematsu, Y.; Ishizawa, K.; Tsuchiya, K.; Obata, T.; Ebina, Y.; Tomita, S.; Tamaki, T. ERK1/2 activation by angiotensin II inhibits insulininduced glucose uptake in vascular smooth muscle cells. Exp. Cell Res., 2005, 308(2), 291-299.
43. Nazari, H.; Takahashi, A.; Harada, N.; Mawatari, K.; Nakano, M.; Kishi, K.; Ebina, Y.; Nakaya, Y. Angiotensin II inhibits insulininduced actin stress fiber formation and glucose uptake via ERK1/2. J. Med. Invest., 2007, 54(1-2), 19-27. (Pubitemid 46769060)
44. Alfarano, C.; Sartiani, L.; Nediani, C.; Mannucci, E.; Mugelli, A.; Cerbai, E.; Raimondi, L. Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells). Br. J. Pharmacol., 2008, 153(5), 907- 914. (Pubitemid 351328928)
45. Tan, Y.; Ichikawa, T.; Li, J.; Si, Q.; Yang, H.; Chen, X.; Goldblatt, C.S.; Meyer, C.J.; Li, X.; Cai, L.; Cui, T. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes, 2011, 60(2), 625-633.
46. Yu, Z.; Shao, W.; Chiang, Y.; Foltz, W.; Zhang, Z.; Ling, W.; Fantus, I.G.; Jin, T. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia, 2011, 54(4), 922-934.
47. He, X.; Kan, H.; Cai, L.; Ma, Q. Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J. Mol. Cell Cardiol., 2009, 46(1), 47-58.
48. Li, B.; Liu, S.; Miao, L.; Cai, L. Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy. Exp. Diabetes Res., 2012, 2012, 216512.
49. Freigang, S.; Ampenberger, F.; Spohn, G.; Heer, S.; Abdijapar, T.; Shamshiev.; Kisielow, J.; Hersberger, M.; Yamamoto, M.; Martin, F.; Bachmann.; Kopf, M. Nrf2 is essential for cholesterol crystalinduced inflammasome activation and exacerbation of atherosclerosis. Eur. J. Immunol., 2011, 41(7), 2040-2051.
50. Nagy, L.; Tontonoz, P.; Alvarez, J.G.; Chen, H.; Evans, R, M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell., 1998, 93(2), 229-240. (Pubitemid 28180856)
51. Escargueil-Blanc, I.; Salvayre, R.; Vacaresse, N.; Jurgens, G.; Darblade, B.; Arnal, J.F.; Parthasarathy, S.; Negre-Salvayre, A. Mildly oxidized LDL induces activation of platelet-derived growth factor beta-receptor pathway. Circulation, 2001, 104(5), 1814-1821. (Pubitemid 32963348)
52. Glass, C.K.; Witztum, J.L. Atherosclerosis: the road ahead. Cell, 2001, 104(4), 503-516. (Pubitemid 32201946)
53. Bea, F.; Hudson, F.N.; Chait, A.; Kavanagh, T.J.; Rosenfeld, M.E. Induction of Glutathione Synthesis in Macrophages by Oxidized Low-Density Lipoproteins Is Mediated by Consensus Antioxidant Response Elements. Circ. Res., 2003, 92(4), 386-393. (Pubitemid 36298198)
54. Yoshida, K.; Hirokawa, J.; Tagami, S.; Kawakami, Y.; Urata, Y.; Kondo, T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia, 1995, 38(2), 201-210.
55. Sharma, A.; Kharb, S.; Chugh, SN.; Kakkar, R.; Singh, G.P. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism, 2000, 49(2), 160-162. (Pubitemid 30090877)
56. Parl, F.F. Glutathione S-transferase genotypes and cancer risk. Cancer Lett., 2005, 221(2), 123-129. (Pubitemid 40460398)
57. Bolt, H.M.; Their, R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab., 2006, 7(6), 613-628. (Pubitemid 44226589)
58. Saito-Yamanaka, N.; Yamanaka, H.; Nagasawa, S. Glutathionerelated detoxication functions in streptozotocin-induced diabetic rats. J. Vet. Med. Sci., 1993, 55(6), 991-994.
59. Autrup, H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res., 2000, 464(1), 65-76. (Pubitemid 30035291)
60. d'Errico A.; Taioli, E.; Chen, X.; Vineis, P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1996, 1(3), 149-173. (Pubitemid 126710667)
61. Zimniak, P.; Nanduri, B.; Pikuła, S.; Bandorowicz-Pikuła, J.; Singhal, S.S.; Srivastava, S.K.; Awasthim S.; Awasthi, Y.C. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem., 1994, 224(3), 893-899. (Pubitemid 24288851)
62. Sundberg, K.; Johansson, A.S.; Stenberg, G.; Widersten, M.; Seidel, A.; Mannervik, B.; Jernstrom, B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 1998, 19(3), 433-436. (Pubitemid 28375445)
63. Zhong, S.L.; Zhou, S.F.; Chen, X.; Chan, S.Y.; Chan, E.; Ng, K.Y.; Duan, W.; Huang, M. Relationship between genotype and enzyme activity of glutathione Stransferases M1 and P1 in Chinese. Eur. J Pharm. Sci., 2006, 28(1-2), 77-85.
64. Wang, L.S.; Tang, J.J.; Tang, N.P.; Wang, M.W.; Yan, J.J.; Wang, Q.M.; Yang, Z.J.; Wang, B. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin. Chem. Lab. Med., 2008, 46(12), 1720-1725.
65. Singh, N.; Sinha, N.; Kumar, S.; Pandey, C.M.; Agrawal, S. Glutathione S-Transferase Gene Polymorphism as a Susceptibility Factor for Acute Myocardial Infarction and Smoking in the North Indian Population. Cardiology, 2011, 118(1), 16-21.
66. Probst-Hensch, N.M.; Imboden, M.; Dietrich, F.D.; Barthelemy, J.C.; Ackermann-Liebrich, U.; Berger, W.; Gaspoz, J.M.; Schwartz, J. Glutathione S-Transferase Polymorphisms, Passive Smoking, Obesity, and Heart Rate Variability in Nonsmokers. Ursula Ackermann-Liebrich, 2 Wolfgang Berger, 4 Jean-Michel Gaspoz, and Joel Schwartz. Environ. Health Perspect., 2008, 116(11), 1494-1499.
67. Masetti, S.; Botto, N.; Manfredi, S.; Colombo, M.G.; Rizza. A.; Vassalle, C.; Clerico, A.; Biagini, A.; Andreassi, M.G. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J. Mol. Med. (Berl), 2003, 81(8), 488-494. (Pubitemid 37070201)
68. Kim, S.J.; Kim, M.G.; Kim, K.S.; Song, J.S.; Yim, S.V.; Chung, J.H. Impact of Glutathione S-Transferase M1 and T1 Gene Polymorphisms on the Smoking-Related Coronary Artery Disease. J. Korean Med. Sci., 2008, 23(3), 365-372.
69. Ramprasath, T.; Senthil Murugan, P.; Prabakaran, A.D.; Gomathi, P.; Rathinavel, A.; Selvam, G.S. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem. Biophys. Res. Commun., 2011, 407(1), 49-53.
70. Miller, E.A.; Pankow, J.S.; Millikan, R.C.; Bray, M.S.; Ballantyne, C.M.; Bell, D.A.; Heiss, G.; Li, R. Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis, 2003, 171(2), 265-272. (Pubitemid 37486079)
71. Doney, A.S.; Lee, S.; Leese, G.P.; Morris, A.D.; Palmer, C.N. Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta-Null Genotype: A Go-DARTS Study. Circulation, 2005, 111(22), 2927-2934. (Pubitemid 40814185)
72. Türkanoǧlu, A.; Demirdöǧen, B.C.; Demirkaya, S.; Bek, S.; Adal, O. Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk. Neurol. Sci., 2010, 31(6), 727-734.
73. Maciel, S.S.; Pereira Ada, C.; Silva, G.J.; Rodrigues, M.V.; Mill, J.G.; Krieger, J.E. Association between glutathione S-transferase polymorphisms and triglycerides and HDL-cholesterol. Atherosclerosis, 2009, 206(1), 204-208.
74. Wang, G.; Zhang, L.; Li, Q. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem. Biophys. Res. Commun., 2006, 341(2), 310-313. (Pubitemid 43152107)
75. Gonul, N.; Kadioglu, E.; Kocabaş, N.A.; Ozkaya, M.; Karakaya, A.E.; Karahalil, B. The role of GSTM1, GSTT1, GSTP1, and OGG1 polymorphisms in type 2 diabetes mellitus risk: A casecontrol study in a Turkish population. Gene, 2012, 505(1), 121-127.
76. Bid, H.K.; Konwar, R.; Saxena, M.; Chaudhari, P.; Agrawal, C.G.; Banerjee, M. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J. Postgrad. Med., 2010, 56(3), 176-181.
77. Taspinar, M.; Aydos, S.; Sakiragaoglu, O.; Duzen, I.V.; Yalcinkaya, A.; Oztuna, D.; Bardakci, H.; Tutar, E.; Sunguroglu, A. Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease. DNA Cell Biol., 2012, 31(2), 211-218.
78. Tang, J.J.; Wang, M.W.; Jia, E.Z.; Yan, J.J.; Wang, Q.M.; Zhu, J.; Yang, Z.J.; Lu, X.; Wang, L.S. The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study. Mol. Biol. Rep., 2010, 37(1), 405-410.
79. Tamer, L.; Ercan, B.; Camsari, A.; Yildirim, H.; Ciçek, D.; Sucu, N.; Ateş, N.A.; Atik, U. Glutathione S-transferase gene smokingrelated coronary artery disease. Basic Res. Cardiol., 2004, 99(3), 223-229.
80. Arthur, J.R. The glutathione peroxidases. Cell Mol. Life Sci., 2000, 57 (13-14), 1825-1835. (Pubitemid 32102578)
81. Jablonska, E.J.; Gromadzinska, E.; Reszka, W.; Wasowicz, W.; Sobala, N.; Szeszenia-Dabrowska, P.; Boffetta, P. Association between GPx-1 Pro198Leu polymorphism, GPx-1 activity and plasma selenium concentration in humans. Eur. J. Nutr., 2009, 48(6), 383-386.
82. Cheng, W. H.; Ho, Y. S.; Valentine, B. A.; Ross, D. A.; Combs, G. F. Jr.; Lei, X. G. Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J. Nutr., 1998, 128 (7), 1070-1076. (Pubitemid 28317668)
83. Torzewski, M.; Ochsenhirt, V.; Kleschyov, A.L.; Oelze, M.; Daiber, A.; Li, H.; Rossmann, H.; Tsimikas, S.; Reifenberg, Kurt.; Cheng, Fei.; Hans-Anton, L.; Stefan, B.; Forstermann, U.; Munzel, T.; Lackner, K.J. Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein EDeficient Mice. Arterioscler. Thromb. Vasc. Biol., 2007, 27(4), 850-857. (Pubitemid 46606716)
84. 't Hoen, P.A.; Van der, Lans, C.A.; Van Eck, M.; Bijsterbosch, M.K.; Van Berkel, T.J.; Twisk, J. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ. Res., 2003, 93(3), 262-269. (Pubitemid 36993238)
85. Collins, A.R.; Lyon, C.J.; Xia, X.; Liu, J.Z.; Tangirala, R.K.; Yin, F.; Boyadjian, R.; Bikineyeva, A.; Praticó, D.; Harrison, D.G.; Hsueh, W.A. Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes. Circ. Res., 2009, 104(6), e42-e54.
86. Lewis, P.; Stefanovic, N.; Pete, J.; Calkin, A.C.; Giunti, S.; Thallas-Bonke, V.; Jandeleit-Dahm, K.A.; Allen, T.J.; Kola, I.; Cooper, M.E.; de Haan, J.B. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation, 2007, 115(16), 2178-2187. (Pubitemid 46659070)
87. Forgione, M.A.; Weiss, N.; Heydrick, S.; Cap, A.; Klings, E.S.; Bierl, C.; Eberhardt, R.T.; Farber, H.W.; Loscalzo, J. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol., 2002, 282(4), H1255-H1261. (Pubitemid 34654876)
88. Dayal, S.; Brown, K.L.; Weydert, C.J.; Oberley. L.W.; Arning, E.; Bottiglieri, T.; Faraci, F.M.; Lentz, S.R. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol., 2002, 22(12), 1996-2002. (Pubitemid 36025205)
89. Weiss, N.; Heydrick, S.; Zhang, Y.Y.; Bierl, C.; Cap, A.; Loscalzo, J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler. Thromb. Vasc. Biol., 2002, 22(1), 34-41. (Pubitemid 34076229)
90. Bhabak, K.P.; Mugesh, G. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc. Chem. Res., 2010, 43(11), 1408-1419.
91. Kucukgergin, C.; Gokpinar, M.; Sanli, O. Tefik, T.; Oktar, T.; Seckin, S. Association between genetic variants in glutathione peroxidase 1 (GPx-1) gene, GPx activity and the risk of prostate cancer. Minerva Urol. Nefrol., 2011, 63(3), 183-190.
92. Hamanishi, T.; Furuta, H.; Kato, H.; Doi, A.; Tamai, M.; Shimomura, H.; Sakagashira, S.; Nishi, M.; Sasaki, H.; Sanke, T, Nanjo K. Functional Variants in the Glutathione Peroxidase-1 (GPx-1) Gene Are Associated With Increased Intima-Media Thickness of Carotid Arteries and Risk of Macrovascular Diseases in Japanese Type 2 Diabetic Patients. Diabetes, 2004, 53(9), 2455-2460. (Pubitemid 39145603)
93. Nemoto, M.; Nishimura, R.; Sasaki, T.; Hiki, Y.; Miyashita, Y.; Nishioka, M.; Fujimoto, K.; Sakuma, T.; Ohashi, T.; Fukuda, K.; Eto, Y.; Tajima, N. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc. Diabetol., 2007, 6, 23.
94. Tang, N.P.; Wang, L.S.; Yang, L.; Gu, H.J.; Sun, Q.M.; Cong, R.H.; Zhou, B.; Zhu, H.J.; Wang, B. Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clin. Chim. Acta., 2008, 395(1-2), 89-93.
95. Ramprasath, T.; Murugan, P.S.; Kalaiarasan, E.; Gomathi, P.; Rathinavel, A.; Selvam, G.S. Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes. Mol. Cell Biochem., 2012, 361(1-2), 143-150.
96. Lei, C.; Niu, X.; Wei, J.; Zhu, J.; Zhu, Y. Interaction of glutathione peroxidase-1 and selenium in endemic dilated cardiomyopathy. Clin. Chim. Acta., 2008, 399(1-2), 102-108.
97. Kuzuya, M.; Ando, F.; Iguchi, A.; Shimokata, H. Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. Am. J. Clin. Nutr., 2008, 87(6), 1939-1944. (Pubitemid 351872662)
98. Ross, D.; Kepa, J.K.; Winski, S.L.; Beall, H.D.; Anwar, A.; Siegel, D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact., 2000, 129(1-2), 77-97. (Pubitemid 32061055)
99. Siegel, D.; Ross, D. Immunodetection of NAD (P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic. Biol. Med., 2000, 29(3-4), 246-253.
100. Iida, A.; Sekine, A.; Saito, S.; Kitamura, Y.; Kitamoto, T.; Osawa, S.; Mishima, C.; Nakamura, Y. Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes. J. Hum. Genet., 2001, 46(4), 225-240. (Pubitemid 32435607)
101. Siegel, D.; Gustafson, D.L.; Dehn, D.L.; Han, J.Y.; Boonchoong, P.; Berliner, L.J.; Ross, D. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol. Pharmacol., 2004, 65(5), 1238-1247. (Pubitemid 38543494)
102. Long, D.J.; 2nd, Waikel, R.L.; Wang, X.J.; Roop, D.R.; Jaiswal, A.K. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7, 12-dimethylbenz[a]-anthracene-induced carcino genesis in mouse skin. J. Natl. Cancer Inst., 2001, 93(15), 1166-1170. (Pubitemid 32780969)
103. Iskander, K.; Paquet, M.; Brayton, C.; Jaiswal, A.K. Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7, 12-dimethylbenz(a) anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res., 2004, 64(17), 5925-5928. (Pubitemid 39129385)
104. Palming, J.; Sjoholm, K.; Jernas, M.; Theodore, C.; Lystig.; Gummesson, A.; Romeo, S.; Lonn, L.; Lonn, M.; Carlsson, B.; Lena.; Carlsson, M.S. The Expression of NAD(P)H:Quinone Oxidoreductase 1 Is High in Human Adipose Tissue, Reduced by Weight Loss, and Correlates with Adiposity, Insulin Sensitivity, and Markers of Liver Dysfunction. J. Clin. Endocrinol. Metab., 2007, 92(6), 2346-2352. (Pubitemid 46997144)
105. Ungvari, Z.; Bailey-Downs, L.; Gautam, T.; Jimenez, R.; Losonczy, G.; Zhang, C.; Ballabh, P.; Recchia, FA.; Wilkerson, DC.; Sonntag, WE.; Pearson, K.; de, Cabo, R.; Csiszar, A. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am. J. Physiol. Heart Circ. Physiol., 2011, 300 (4), H1133-H1140.
106. Gaedigk, A.; Tyndale, R.F.; Jurima-Romet, M.; Sellers, E.M.; Grant, D.M.; Leeder, J.S.; NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics, 1998, 8(4), 305-313. (Pubitemid 28372324)
107. Shyu, H.Y.; Fong, C.S.; Fu, Y.P.; Shieh, J.C.; Yin, J.H.; Chang, C.Y.; Wang, H.W.; Cheng, C.W. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke. Clin. Chim. Acta., 2010, 411(11-12), 840-845.
108. Potenza, M.A.; Gagliardi, S.; Nacci, C.; Carratu, M.R.; Montagnani, M. Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets. Curr. Med. Chem., 2009, 16(1), 94-112.
109. Lyssenko, V.; Jonsson, A.; Almgren, P.; Pulizzi, N.; Isomaa, B.; Tuomi, T.; Berglund, G.; Altshuler, D.; Nilsson, P.; Groop, L. Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes. N. Engl. J. Med., 2008, 359(21), 2220-2232.